Modulating the Tumor Microenvironment via Oncolytic Viruses and CSF-1R Inhibition Synergistically Enhances Anti-PD-1 Immunotherapy

Gang Shi; Qianmei Yang; Yujing Zhang; Qingyuan Jiang; Yi Lin; Shenshen Yang; Huiling Wang; Lin Cheng; Xin Zhang; Yimin Li; Qingnan Wang; Yi Liu; Qin Wang; Hantao Zhang; Xiaolan Su; Lei Dai; Lei Liu; Shuang Zhang; Li Jia; Zhi Li; Yang Yang; Dechao Yu; Yuquan Wei; Hongxin Deng

doi:10.1016/j.ymthe.2018.11.010

JOURNAL ARTICLE

Modulating the Tumor Microenvironment via Oncolytic Viruses and CSF-1R Inhibition Synergistically Enhances Anti-PD-1 Immunotherapy

Gang Shi Qianmei Yang Yujing Zhang Qingyuan Jiang Yi Lin Shenshen Yang Huiling Wang Lin Cheng Xin Zhang Yimin Li Qingnan Wang Yi Liu Qin Wang Hantao Zhang Xiaolan Su Lei Dai Lei Liu Shuang Zhang Li Jia Zhi Li Yang Yang Dechao Yu Yuquan Wei Hongxin Deng

Year: 2018 Journal: Molecular Therapy Vol: 27 (1)Pages: 244-260 Publisher: Elsevier BV

DOI: 10.1016/j.ymthe.2018.11.010

Get Full-Text PDF Get Analytical Report

Keywords:

Oncolytic virus Immunotherapy Tumor microenvironment Cancer research Cancer immunotherapy Chemistry Immune system Medicine Tumor cells Biology Virology Immunology

Metrics

109

Cited By

6.00

FWCI (Field Weighted Citation Impact)

Refs

0.97

Citation Normalized Percentile

Is in top 1%

Is in top 10%

Citation History

Topics

Virus-based gene therapy research

Life Sciences → Biochemistry, Genetics and Molecular Biology → Genetics

Cancer Research and Treatments

Life Sciences → Biochemistry, Genetics and Molecular Biology → Biotechnology

CAR-T cell therapy research

Health Sciences → Medicine → Oncology

Modulating the Tumor Microenvironment via Oncolytic Viruses and CSF-1R Inhibition Synergistically Enhances Anti-PD-1 Immunotherapy

Metrics

Citation History

Topics

Related Documents

Clofazimine enhances anti-PD-1 immunotherapy in glioblastoma by inhibiting Wnt6 signaling and modulating the tumor immune microenvironment

Modification of the Tumor Microenvironment Enhances Anti-PD-1 Immunotherapy in Metastatic Melanoma

Oncolytic adenoviruses synergistically enhance anti-PD-L1 and anti-CTLA-4 immunotherapy by modulating the tumour microenvironment in a 4T1 orthotopic mouse model

1086 Modulating the tumor microenvironment via hypoxia activated prodrug CPD100Li induced cell death synergistically enhances anti-CTLA-4 immunotherapy

PD-L1 in tumor microenvironment mediates resistance to oncolytic immunotherapy